Obesity and sex steroid changes across puberty: Evidence for marked hyperandrogenemia in pre- and early pubertal obese girls

University of California, San Diego, San Diego, California, United States
Journal of Clinical Endocrinology &amp Metabolism (Impact Factor: 6.31). 02/2007; 92(2):430-6. DOI: 10.1210/jc.2006-2002
Source: PubMed

ABSTRACT Peripubertal obesity is associated with abnormal sex steroid concentrations, but the timing of onset and degree of these abnormalities remain unclear.
The objective of the study was to assess the degree of hyperandrogenemia across puberty in obese girls and assess overnight sex steroid changes in Tanner stage 1-3 girls.
This was a cross-sectional analysis.
The study was conducted at general clinical research centers.
Thirty normal-weight (body mass index for age < 85%) and 74 obese (body mass index for age >or= 95%) peripubertal girls.
Blood samples (circa 0500-0700 h) were taken while fasting. Samples from the preceding evening (circa 2300 h) were obtained in 23 Tanner 1-3 girls.
Hormone concentrations stratified by Tanner stage were measured.
Compared with normal-weight girls, mean free testosterone (T) was elevated 2- to 9-fold across puberty in obese girls, whereas fasting insulin was 3-fold elevated in obese Tanner 1-3 girls (P < 0.05). Mean LH was lower in obese Tanner 1 and 2 girls (P < 0.05) but not in more mature girls. In a subgroup of normal-weight Tanner 1-3 girls (n = 17), mean progesterone (P) and T increased overnight 2.3- and 2.4-fold, respectively (P <or= 0.001). In obese Tanner 1-3 girls (n = 6), evening P and T were elevated, and both tended to increase overnight [mean 1.4- and 1.6-fold, respectively (P = 0.06)].
Peripubertal obesity is associated with hyperandrogenemia and hyperinsulinemia throughout puberty, being especially marked shortly before and during early puberty. P and T concentrations in normal-weight Tanner 1-3 girls increase overnight, with similar but less evident changes in obese girls.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Context: Polycystic ovary syndrome (PCOS) confers an increased risk for type 2 diabetes in affected women as early as adolescence. First-degree relatives (FDRs) of affected women are at increased risk for associated reproductive and metabolic phenotypes. Objective: We sought to prospectively assess insulin sensitivity and secretion and to measure reproductive hormone levels using sensitive techniques. Design, Setting and Participants: Twelve premenarchal FDR girls and 10 control girls of comparable age, Tanner stage and BMI were studied at an academic medical center. Interventions: Frequently sampled intravenous glucose tolerance tests and oral glucose tolerance tests were performed. Main Outcome Measures: Reproductive hormone levels, lipid profiles, glucose tolerance and frequently sampled intravenous glucose tolerance test parameters of insulin sensitivity and secretion were investigated. Results: Disposition index (DI), insulin secretion corrected for insulin sensitivity, was decreased in FDR compared to control girls at baseline (p=0.01), independent of dysglycemia. Decreases in DI persisted in FDR girls during 2-year follow-up (p=0.003). Testosterone (T) levels were increased (p=0.02) in FDR compared to control girls at baseline but this difference did not persist as T levels increased in control girls. Conclusions: DI is decreased in peripubertal FDR girls and this decrease persists as puberty progresses. These findings suggest that β-cell dysfunction is an early defect in glucose homeostasis preceding decompensation in glucose tolerance in FDR girls. T levels were increased in FDR girls earlier than previously reported but these changes did not persist suggesting an earlier onset of pubertal increases in glandular androgen secretion in FDR girls.
    Journal of Clinical Endocrinology &amp Metabolism 07/2014; 99(10):jc20141474. DOI:10.1210/jc.2014-1474 · 6.31 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: There is evidence for differences between endocrinologists and other specialists in their approach to diagnosis and management of the polycystic ovary syndrome (PCOS). Objective: A mailed survey consisting of a simple questionnaire aiming to understand current practice for diagnosis and management of the PCOS by specialists across Europe. Methods: The questionnaire consisted of 23 questions grouped to achieve information on (i) the general characteristics of the respondents, (ii) patients with PCOS seen by endocrinologists (iii) the main diagnostic criteria (iv) biochemical parameters used in the differential diagnosis of hyperandrogenism, (v) long-term concerns and, finally (vi) treatment choices. A total of 357 questionnaires, representing 13.3% of the members of ESE were available for final analysis; 93% of the respondents were endocrinologists Results: In relation to the diagnostic criteria, respondents were most likely to select menstrual irregularity as the most frequent criteria used for the diagnosis of PCOS although very high rates were achieved for the use of hirsutism and biochemical hyperandrogenism. It therefore appears that the NIH criteria were followed by the majority of respondents. The most frequent biochemical parameters in the differential diagnosis of hyperandrogenism were total testosterone or free androgen index (FAI). Obesity and type 2 diabetes were regarded as the principal long-term concerns for PCOS. The most common treatments for patients with PCOS were metformin (33%), lifestyle modification (25%), and oral contraceptives (22%). More direct treatments of infertility, such as clomiphene citrate alone or combined with metformin were prescribed by 9% and 23%, respectively, whereas only 6% used other methods for induction of ovulation. Conclusion: The survey the ESE has produced is a good start for evaluating the perspective in the diagnosis and treatment of PCOS by endocrinologists in Europe.
    European Journal of Endocrinology 07/2014; 171(4). DOI:10.1530/EJE-14-0252 · 3.69 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Are there abnormalities in gonadotrophin secretion, adrenal steroidogenesis and/or testicular steroidogenesis in brothers of women with polycystic ovary syndrome (PCOS)?
    Human Reproduction 10/2014; 29(12). DOI:10.1093/humrep/deu282 · 4.59 Impact Factor


Available from